发明授权
US08198306B2 Methods for treatment of multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione in combination with a proteasome inhibitor 有权
使用3-(4-氨基-1-氧代-1,3-二氢异吲哚-2-基) - 哌啶-2,6-二酮与蛋白酶体抑制剂联合治疗多发性骨髓瘤的方法

  • 专利标题: Methods for treatment of multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione in combination with a proteasome inhibitor
  • 专利标题(中): 使用3-(4-氨基-1-氧代-1,3-二氢异吲哚-2-基) - 哌啶-2,6-二酮与蛋白酶体抑制剂联合治疗多发性骨髓瘤的方法
  • 申请号: US12640702
    申请日: 2009-12-17
  • 公开(公告)号: US08198306B2
    公开(公告)日: 2012-06-12
  • 发明人: Jerome B. Zeldis
  • 申请人: Jerome B. Zeldis
  • 申请人地址: US NJ Summit
  • 专利权人: Celgene Corporation
  • 当前专利权人: Celgene Corporation
  • 当前专利权人地址: US NJ Summit
  • 代理机构: Jones Day
  • 主分类号: A01N43/40
  • IPC分类号: A01N43/40
Methods for treatment of multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione in combination with a proteasome inhibitor
摘要:
Methods of treating, preventing and/or managing cancer as well as and diseases and disorders associated with, or characterized by, undesired angiogenesis are disclosed. Specific methods encompass the administration of an immunomodulatory compound alone or in combination with a second active ingredient. The invention further relates to methods of reducing or avoiding adverse side effects associated with chemotherapy, radiation therapy, hormonal therapy, biological therapy or immunotherapy which comprise the administration of an immunomodulatory compound. Pharmaceutical compositions, single unit dosage forms, and kits suitable for use in methods of the invention are also disclosed.
信息查询
0/0